3178 results for «310»
3178 results
Featured cases - Challenging tricuspid interventions (Part 2)
24 Nov 2024 – From PCR London Valves 2024
Dive into this session showcasing a diverse array of challenging tricuspid interventions from the PCR London Valves 2024 Clinical Cases submissions. Discover complex cases involving TTVR in a transplanted heart, recurrent tricuspid regurgitation after T-TEER, and an extremely difficult tricuspid valve-in-valve implantation. Gain insights on navigating...
Featured cases - TAVI coronary complications
24 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected PCR London Valves 2024 Clinical Cases submissions on TAVI coronary complications. Explore a case of post-TAVR acute pulmonary edema, an unusual inter-TAVI diastolic gradient, late coronary artery occlusion after TAVR-in-SAVR, acute coronary syndrome after TAVI due to subacute left main...
Featured cases - Atrial septal challenges during mitral TEER
24 Nov 2024 – From PCR London Valves 2024
Delve into this session showcasing selected PCR London Valves 2024 Clinical Cases submissions that highlight the complexities and challenges associated with atrial septal issues during mitral TEER procedures. Explore cases involving a bailout strategy to manage acute single leaflet detachment during Mitraclip, navigating a challenging transseptal...
How to establish a mitral TEER programme
24 Nov 2024 – From PCR London Valves 2024
Ready to start your journey toward establishing a mitral TEER programme? This video covers everything you need to know—from understanding the contemporary role of TEER in managing mitral regurgitation to building a Heart Team and referral network.
Learn how to find your first cases, select the right...
Rapid-fire - Mitral and tricuspid interventions
24 Nov 2024 – From PCR London Valves 2024
Dive into this rapid-fire session featuring selected PCR London Valves 2024 Clinical Cases submissions on mitral and tricuspid interventions. Explore complex cases involving staged TMVR and combined T-TEER with transcatheter atrial septum defect occlusion, managing a pulmonary artery rupture during TTVR, preventing and treating air gas...
TAVI innovations: latest breakthroughs from PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Curious about the latest advancements shaping the future of TAVI? Don't miss this video which deliver insights from the PCR London Valves 2024 Late-Breaking Trials, diving into key topics that matter most in clinical practice.
Explore 5-year outcomes of AVR in low-risk patients stratified by annulus size,...
Featured research - Aortic valve (Part 3)
24 Nov 2024 – From PCR London Valves 2024
Featured Research - Aortic valve (Part 5)
25 Nov 2024 – From PCR London Valves 2024
This session features a selection of research abstracts from PCR London Valves 2024, covering a wide range of topics related to aortic valve interventions. Explore insights on predicting pacemaker need after TAVI, the impact of commissural misalignment and leaflet laceration, long-term outcomes with different valve types,...
Featured cases - TAVI-in-TAVI (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Featured research - Aortic valve (Part 4)
24 Nov 2024 – From PCR London Valves 2024
Featured Cases - TAVI embolisation (Part 2)
25 Nov 2024 – From PCR London Valves 2024
This session features a selection of challenging TAVI cases from PCR London Valves 2024, focusing on the management of TAVI embolization and unexpected events. Learn from real-world experiences on handling transcatheter aortic valve dislodgement, migration, and other complications, and discover innovative techniques for successful bailout strategies.
SEISMIC-HF I - Exploring non-invasive methods for monitoring intracardiac filling pressures
16 Nov 2024
Luis Ortega provides his take on the SEISMIC-HF I study presented by Liviu Klein at AHA 2024, in Chicago.
Author
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events
01 Sep 2022
Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.
Author
UNIVERSAL: routine ultrasonography guidance for femoral vascular access for cardiac procedures - A randomized clinical Trial
19 Sep 2022
Ali Nazmi Calik provides his take on UNIVERSAL randomized clinical trial, which questioned whether routine ultrasonography guidance for CFA access for cardiac procedures reduces bleeding or vascular complications. This trial was presented by Sanjit S. Jolly during TCT 2022.
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
